D. B. Rodgers

A Systems Approach to Understanding Transformation in Learning Communities

M. J. Fleener, D. B. Rodgers, 1999 .

Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis. Results of two randomized treatment trials of six weeks duration.

H. S. Lu, D. B. Rodgers, G. Pasero, 2002, Scandinavian journal of rheumatology.

Onset of pain relief with rofecoxib in chronic low back pain: results of two four-week, randomized, placebo-controlled trials*

D. B. Rodgers, D. Krupa, Nathaniel Katz, 2004, Current medical research and opinion.

A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]

D. B. Rodgers, C. Lines, B. Gertz, 2002, BMC family practice.

Tolerability profiles of rofecoxib (Vioxx) and Arthrotec. A comparison of six weeks treatment in patients with osteoarthritis.

D. B. Rodgers, B. Pons-Estel, M. Laurenzi, 2001, Scandinavian journal of rheumatology.

Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis

D. B. Rodgers, G. Pasero, C. Zerbini, 2002 .